Prevention of spontaneous prostate‐related cancer in Lobund‐Wistar rats by a soy protein isolate/isoflavone diet

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Prostate

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0045(20001001)45:2<101::AID-PROS3>3.0.CO;2-PPMID 11027408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate

  2004cited by this paper
• Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats.

  2000cited by this paper
• Prostate‐seminal vesicle cancers induced in noble rats

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Soy, soy phytoestrogens (isoflavones), and breast cancer.

  1999cited by this paper
• Phytoestrogen content of purified, open- and closed-formula laboratory animal diets.

  1999cited by this paper
• Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.

  1999cited by this paper
• Workgroup I: Rodent models of prostate cancer

  1998cited by this paper
• Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones.

  1998cited by this paper
• Dihydrotestosterone prevents spontaneous adenocarcinomas in the prostate-seminal vesicle in aging L-W rats.

  1998cited by this paper
• Lobund‐Wistar rat model of prostate cancer in man

  1998cited by this paper
• Dihydrotestosterone prevents spontaneous adenocarcinomas in the prostate‐seminal vesicle in aging L‐W rats

  1998cited by this paper
• Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats.

  1997cited by this paper
• Androgen deprivation as a strategy for prostate cancer chemoprevention.

  1997cited by this paper
• CHAPTER 20 – Hormones and Cancer

  1997cited by this paper
• Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet.

  1995cited by this paper
• Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids.

  1995cited by this paper
• Isoflavone content in commercial soybean foods

  1994cited by this paper
• Hereditary prostate cancer: epidemiologic and clinical features.

  1993cited by this paper
• Lipid risk factors and atherosclerosis: what do we measure?

  1990cited by this paper
• Western diet and Western diseases: some hormonal and biochemical mechanisms and associations.

  1990cited by this paper
• Prevention and treatment of experimental prostate cancer in lobund‐wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration

  1989cited by this paper
• Variability in diet and its relation to risk in ethnic and migrant groups.

  1988cited by this paper
• Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986.

  1988cited by this paper
• Serum testosterone levels in healthy young black and white men.

  1986cited by this paper
• Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease.

  1984cited by this paper
• Endogenous hormones as a major factor in human cancer.

  1982cited by this paper
• Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France

  1977cited by this paper
• Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices

  1975cited by this paper
• Stock diet for colony production of germfree rats and mice.

  1969cited by this paper
• Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States.

  1968cited by this paper

• Role of isoflavones in multiple sclerosis

  2025cites this paper
• The role of isoflavones in augmenting the effects of radiotherapy

  2023cites this paper
• Phytosterols activating nuclear receptors are involving in steroid hormone-dependent cancers: Myth or fact?

  2023cites this paper
• Lunasin and Its Epigenetic Impact in Cancer Chemoprevention

  2023cites this paper
• The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer

  2023cites this paper
• The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects

  2023cites this paper
• Plants as a Source of Anticancer Agents: From Bench to Bedside

  2022cites this paper
• Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation

  2020cites this paper
• Gnotobiotics and the Microbiome

  2019cites this paper
• Modelling human prostate cancer: Rat models

  2018cites this paper
• Is There a Future for Chemoprevention of Prostate Cancer?

  2016cites this paper
• The Development, Sensory Evaluation and Interconversion of Bioactive Isothiocyanates in a Tomato-Soy-Arugula Seed Beverage

  2015cites this paper
• Plant Polyphenols as Chemopreventive Agents

  2014cites this paper
• Phytoestrogens and Hepatocellular Carcinoma Chemoprevention

  2014cites this paper
• Soybean and Prostate Cancer

  2013cites this paper
• Xenograft, Transgenic, and Knockout Models of Prostate Cancer

  2013cites this paper
• Animal Models of human Cancer

  2013cites this paper
• Dietary patterns and prostatic diseases.

  2012cites this paper
• Risks and benefits of dietary isoflavones for cancer

  2011cites this paper
• Vitamin D metabolism and action in the prostate: implications for health and disease.

  2011influential citation
• Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants – In vivo evidence

  2011cites this paper
• Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.

  2010cites this paper
• Use of cross species genomic profiling identifies pathways and genes differentially regulated in prostate cancer cells treated with soy protein isolates or purified genistein.

  2010cites this paper
• Genistein Induces Growth Inhibition and G2/M Arrest in Nasopharyngeal Carcinoma Cells

  2010cites this paper
• Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen

  2010cites this paper
• Chemopreventive Effects of Dietary Selenium and Soy Isoflavones in a Mouse Model of Prostate Cancer

  2010cites this paper
• [A critical assessment of phytotherapy for prostate cancer].

  2009cites this paper
• Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis.

  2009cites this paper
• Eine kritische Bewertung der Phytotherapie des Prostatakarzinoms

  2009cites this paper
• Soy, isoflavones, and prostate cancer.

  2009cites this paper
• The effect of dietary supplementation with limonene or myo-inositol on the induction of neoplasia and matrix metalloproteinase and plasminogen activator activities in accessory sex organs of male Lobund-Wistar rats.

  2008cites this paper
• The potential role of soyfoods in weight and adiposity reduction: an evidence‐based review

  2008cites this paper
• Molecular and Biochemical Effects of a Kola Nut Extract on Androgen Receptor-Mediated Pathways

  2008cites this paper
• Lunasin: A Novel Cancer Preventive Seed Peptide

  2008cites this paper
• Soy isoflavone genistein in prevention and treatment of prostate cancer

  2008cites this paper
• Facts and Fiction of Phytotherapy for Prostate Cancer : A Critical Assessment of Preclinical and Clinical Data

  2008cites this paper
• Animal Models of Prostate Cancer

  2008cites this paper
• ESTUDIO DEL EFECTO DE LAS PROPIEDADES QUELANTES DE LOS FLAVONOIDES SOBRE SU CAPACIDAD ANTIOXIDANTE TOTAL

  2008cites this paper
• Chemoprevention of Rat Prostate Carcinogenesis by Soy Isoflavones and by Bowman-Birk Inhibitor

  2007cites this paper
• Significance of chemoprevention for prostate cancer development: Experimental in vivo approaches to chemoprevention

  2007cites this paper
• Genistein chemoprevention of prostate cancer in TRAMP mice

  2007cites this paper
• Phytoestrogens and prostate cancer : experimental, clinical, and epidemiological studies

  2007cites this paper
• Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data.

  2007cites this paper
• Inhibition of core histone acetylation by the cancer preventive peptide lunasin.

  2007cites this paper
• Chapter 22 – Gnotobiotics

  2006cites this paper
• An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels.

  2006cites this paper
• Identification of both Myt‐1 and Wee‐1 as necessary mediators of the p21‐independent inactivation of the cdc‐2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein

  2006cites this paper
• Immunohistochemical Study of Cell Proliferation, Bcl-2, p53, and Caspase-3 Expression on Preneoplastic Changes Induced by Cadmium and Zinc Chloride in the Ventral Rat Prostate

  2006cites this paper
• A review of the animal models used to investigate the health benefits of soy isoflavones.

  2006cites this paper
• Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model.

  2006cites this paper
• Endocrine disrupting compounds and prostate cancer.

  2006cites this paper
• Differential effects of soy-containing diets on the reproductive tissues growth and reproductive hormone secretion in male rats.

  2006cites this paper
• Complementary and alternative medicine in the treatment of prostate cancer

  2006cites this paper
• Innovative Technologies: Sweet Deal for Cocoa Production?

  2005cites this paper
• Characterization of Chemical Constituents in Scutellaria baicalensis with Antiandrogenic and Growth-Inhibitory Activities toward Prostate Carcinoma

  2005cites this paper
• Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men.

  2005cites this paper
• Quantitative and immunohistochemical evaluation of PCNA, androgen receptors, apoptosis, and Glutathione‐S‐Transferase P1 on preneoplastic changes induced by cadmium and zinc chloride in the rat ventral prostate

  2005cites this paper
• Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.

  2005cites this paper
• Using Comparative Genomics to Leverage Animal Models in the Identification of Cancer Genes. Examples in Prostate Cancer.

  2005cites this paper
• CHAPTER 94 – Vitamin D and Prostate Cancer

  2005cites this paper
• Soy Consumption and Cancer Prevention

  2005cites this paper
• Hormone-Refractory Prostate Cancer in the Lobund-Wistar Rat

  2005cites this paper
• Isoflavones, Soybean Phytoestrogens, and Cancer

  2005cites this paper
• Activities toward Prostate Carcinoma baicalensis with Antiandrogenic and Growth-Inhibitory Characterization of Chemical Constituents in Scutellaria

  2005cites this paper
• Liquid chromatographic–mass spectrometric determination of genistin and daidzin in soybean food samples after accelerated solvent extraction with modified content of extraction cell

  2004cites this paper
• SOY AND THE PREVENTION OF LIFESTYLE‐RELATED DISEASES

  2004cites this paper
• 72 – Nutrition and the Etiology and Prevention of Prostate Cancer

  2004cites this paper
• The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate.

  2004cites this paper
• The role of isoflavones in cancer chemoprevention.

  2004cites this paper
• Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium

  2004influential citation
• Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial.

  2004cites this paper
• Chemoprevention in prostate cancer.

  2004cites this paper
• Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.

  2004cites this paper
• Prostate cancer chemoprevention: an overview of United States trials.

  2004cites this paper
• Soy Isoflavones: Chemistry, Processing Effects, Health Benefits, and Commercial Production

  2004cites this paper
• Der Verzehr von Soja und das Risiko von Brust- und Prostatakrebs

  2004cites this paper
• Prevalence and patterns of self‐initiated nutritional supplementation in men at high risk of prostate cancer

  2004cites this paper
• Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer

  2004cites this paper
• Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

  2003cites this paper
• Chapter 55 – Antioxidants and Phytotherapy

  2003cites this paper
• Critical review of complementary therapies for prostate cancer.

  2003cites this paper
• Hormone-refractory prostate cancer in the Lobund-Wistar rat.

  2003cites this paper
• Soy leaf lowers the ratio of non-HDL to HDL cholesterol in hamsters.

  2003cites this paper
• Emerging evidence on the role of soy in reducing prostate cancer risk.

  2003cites this paper
• Anti‐androgenic action by red clover‐derived dietary isoflavones reduces non‐malignant prostate enlargement in aromatase knockout (arko) mice

  2003cites this paper
• Critical R eview o f C omplementary T herapies f or Prostate C ancer

  2003cites this paper
• Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings.

  2003cites this paper
• Lifestyle/dietary supplement partial androgen suppression and/or estrogen manipulation. A novel PSA reducer and preventive/treatment option for prostate cancer?

  2002cites this paper
• Difference in flavonoid and isoflavone profile between soybean and soy leaf.

  2002cites this paper
• A new antifungal protein and a chitinase with prominent macrophage-stimulating activity from seeds of Phaseolus vulgaris cv. pinto.

  2002cites this paper
• Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components

  2002cites this paper
• Public Health Implications of Dietary Phytoestrogens

  2002cites this paper
• Do Soy Isoflavones Lower Cholesterol, Inhibit Atherosclerosis, and Play a Role in Cancer Prevention?

  2002cites this paper
• SOY AND THE PREVENTION AND TREATMENT OF CHRONIC DISEASE: A SHORT REVIEW OF THE LITERATURE

  2002cites this paper
• In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens.

  2002cites this paper
• Bottlenecks for metabolic engineering of isoflavone glycoconjugates in Arabidopsis

  2002cites this paper
• Genotoxicity and Carcinogenicity Studies of Soy Isoflavones

  2002cites this paper
• Metabolism and Disposition of Genistein, the Principal Soy Isoflavone

  2002cites this paper
• Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.

  2002cites this paper
• Industrial Processing and Preparation of Isoflavones

  2002cites this paper